Massive NIH–industry project opens portals to target validation

Elie Dolgin • February 27, 2019

Five years in, the US$360 million Accelerating Medicines Partnership is yielding tools to speed up drug discovery for rheumatoid arthritis, lupus, diabetes, Alzheimer disease and Parkinson disease.

Continue reading at Nature Reviews Drug Discovery.

By Elie Dolgin • November 18, 2026
Researchers have some of the first rigorous evidence that pumping iron is worth the effort, though perhaps not for the reason most people expect.
By Elie Dolgin • November 18, 2026
Multi-cancer blood tests have yet to beat standard screenings.